Knight Capital Group’s ResMed RMD Stock Holding History

Knight Capital Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$1.37M	Buy	+30,446	New	+$1.44M	0.03%	766

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LCG

Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Knight Capital Group's RMD Position: Q2 2013 in Review

Knight Capital Group opened a new position in ResMed (RMD) in Q2 2013: 30,446 shares worth $1.37M. The stake represents 0.03% of the portfolio and ranks #766 among its holdings.

313 funds tracked by Wall St. Rank hold RMD as of Q2 2013.

Knight Capital Group held 30,446 shares of ResMed worth $1.37M as of Q2 2013.
ResMed was a new Knight Capital Group position in Q2 2013.
ResMed made up 0.03% of Knight Capital Group's portfolio in Q2 2013, its #766 holding.
313 funds tracked by Wall St. Rank held ResMed as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.